- Home
- NEUP vs AEI Comparison
NEUP vs AEI Comparison
Compare NEUP & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUP
- AEI
- Stock Information
- Founded
- NEUP 1996
- AEI 2014
- Country
- NEUP United States
- AEI United States
- Employees
- NEUP N/A
- AEI N/A
- Industry
- NEUP
- AEI Building operators
- Sector
- NEUP
- AEI Real Estate
- Exchange
- NEUP Nasdaq
- AEI Nasdaq
- Market Cap
- NEUP 9.3M
- AEI 8.8M
- IPO Year
- NEUP N/A
- AEI N/A
- Fundamental
- Price
- NEUP $5.04
- AEI $0.95
- Analyst Decision
- NEUP Strong Buy
- AEI
- Analyst Count
- NEUP 1
- AEI 0
- Target Price
- NEUP $21.00
- AEI N/A
- AVG Volume (30 Days)
- NEUP 21.4K
- AEI 40.3K
- Earning Date
- NEUP 05-15-2025
- AEI 05-14-2025
- Dividend Yield
- NEUP N/A
- AEI N/A
- EPS Growth
- NEUP N/A
- AEI N/A
- EPS
- NEUP N/A
- AEI N/A
- Revenue
- NEUP $662,715.00
- AEI $21,115,899.00
- Revenue This Year
- NEUP N/A
- AEI N/A
- Revenue Next Year
- NEUP N/A
- AEI N/A
- P/E Ratio
- NEUP N/A
- AEI N/A
- Revenue Growth
- NEUP N/A
- AEI N/A
- 52 Week Low
- NEUP $2.12
- AEI $0.46
- 52 Week High
- NEUP $15.24
- AEI $2.61
- Technical
- Relative Strength Index (RSI)
- NEUP N/A
- AEI 57.00
- Support Level
- NEUP N/A
- AEI $0.79
- Resistance Level
- NEUP N/A
- AEI $1.00
- Average True Range (ATR)
- NEUP 0.00
- AEI 0.09
- MACD
- NEUP 0.00
- AEI 0.01
- Stochastic Oscillator
- NEUP 0.00
- AEI 83.33
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.